About Anjan Drug
Anjan Drug is a company based in Chennai (India) founded in 1990 by C Kalaichelvan was acquired by PAG in October 2020.. Anjan Drug has raised $5.28 million across 1 funding round from investors including Evolvence, C Kalaichelvan and K Lalitha. The company has 297 employees as of April 07, 2024. Anjan Drug offers products and services including Valproic Acid, Sodium Valproate, Divalproex Sodium, Magnesium Valporate, and Gabapentin. Anjan Drug operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Chennai, India
- Employees 297 as on 07 Apr, 2024
- Founders C Kalaichelvan
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anjan Drug Private Limited
- Date of Incorporation 01 Aug, 1990
- Jurisdiction Chengalpattu Dt, Tamil Nadu, India
-
Annual Revenue
$36.37 M (USD)60.61as on Mar 31, 2023
-
Net Profit
$6.91 M (USD)123as on Mar 31, 2023
-
EBITDA
$9.83 M (USD)112.52as on Mar 31, 2023
-
Total Equity Funding
$5.28 M (USD)
in 1 rounds
-
Latest Funding Round
$5.28 M (USD), Series A
Jun 05, 2009
-
Investors
Evolvence
& 5 more
-
Employee Count
297
as on Apr 07, 2024
-
Acquired by
PAG
(Oct 12, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anjan Drug
Anjan Drug offers a comprehensive portfolio of products and services, including Valproic Acid, Sodium Valproate, Divalproex Sodium, Magnesium Valporate, and Gabapentin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Active ingredient used in pharmaceutical treatments for neurological disorders.
Key component for antiepileptic and mood-stabilizing medications.
Compound for managing seizures and bipolar disorder in drugs.
Ingredient in formulations for epilepsy and psychiatric conditions.
Active substance for treating nerve pain and seizures.
Unlock access to complete
Funding Insights of Anjan Drug
Anjan Drug has successfully raised a total of $5.28M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.28 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.3M
-
First Round
First Round
(05 Jun 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series A - Anjan Drug | Valuation | Evolvence |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anjan Drug
Anjan Drug has secured backing from 6 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Evolvence, C Kalaichelvan and K Lalitha. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative investment firm
|
Founded Year | Domain | Location | |
|
Private equity investments are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments in India are managed by CX Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anjan Drug
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anjan Drug
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anjan Drug Comparisons
Competitors of Anjan Drug
Anjan Drug operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anjan Drug
Frequently Asked Questions about Anjan Drug
When was Anjan Drug founded?
Anjan Drug was founded in 1990 and raised its 1st funding round 19 years after it was founded.
Where is Anjan Drug located?
Anjan Drug is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Is Anjan Drug a funded company?
Anjan Drug is a funded company, having raised a total of $5.28M across 1 funding round to date. The company's 1st funding round was a Series A of $5.28M, raised on Jun 05, 2009.
How many employees does Anjan Drug have?
As of Apr 07, 2024, the latest employee count at Anjan Drug is 297.
What is the annual revenue of Anjan Drug?
Annual revenue of Anjan Drug is $36.37M as on Mar 31, 2023.
What does Anjan Drug do?
Founded in 1990 in Chennai, India, active pharmaceutical ingredients are produced by Anjan Drug within the pharmaceutical sector, with operations centered on central nervous system treatments. Epilepsy drugs are manufactured as a US-FDA approved producer, adhering to US, European, and British Pharmacopeia standards. Approvals for US and Canadian DMFs, along with a European Certificate of Suitability, have been secured. Clients such as Abbott, Sanofi-Aventis, Mylan, and Actavis are served.
Who are the top competitors of Anjan Drug?
Anjan Drug's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
What products or services does Anjan Drug offer?
Anjan Drug offers Valproic Acid, Sodium Valproate, Divalproex Sodium, Magnesium Valporate, and Gabapentin.
Who are Anjan Drug's investors?
Anjan Drug has 6 investors. Key investors include Evolvence, C Kalaichelvan, K Lalitha, PAG, and Samara Capital.
What is Anjan Drug's valuation?
The valuation of Anjan Drug is $9.07M as of Jun 2009.